Skip to content
LexBuild

Ethics Subcommittee of the Advisory Committee to the Director, Centers for Disease Control and Prevention; Meeting

---
identifier: "/us/fr/00-25710"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Ethics Subcommittee of the Advisory Committee to the Director, Centers for Disease Control and Prevention; Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "00-25710"
section_name: "Ethics Subcommittee of the Advisory Committee to the Director, Centers for Disease Control and Prevention; Meeting"
positive_law: false
currency: "2000-10-06"
last_updated: "2000-10-06"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "00-25710"
document_type: "notice"
publication_date: "2000-10-06"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "65 FR 59848"
fr_volume: 65
---

#  Ethics Subcommittee of the Advisory Committee to the Director, Centers for Disease Control and Prevention; Meeting

In accordance with section 10(a)(2) of the Federal Advisory Committee Act Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following subcommittee meeting.

*Name:* Ethics Subcommittee of the Advisory Committee to the Director, CDC.

*Time and Date:* 9:30 a.m.-5 p.m., October 16, 2000.

*Place:* Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Building 16, Room 5126, Atlanta, Georgia 30333.

*Status:* Open to the public, limited only by the space available. The meeting room accommodates approximately 25 people.

*Purpose:* This subcommittee will anticipate, identify, and propose solutions to strategic and broad ethical issues facing CDC.

*Matters To Be Discussed:* Agenda items will include updates from the Associate director for Science, Dixie E. Snider, M.D., M.P.H.; a discussion on ethical considerations of studies to evaluate the risk of transmission of Human Herpes virus (HHV-8) in international settings; and anticipating issues involved in future decisions regarding this issue.

Agenda items are subject to change as priorities dictate.

*Contact Person for More Information:* Kathy Cahill, Executive Secretary, Advisory Committee to the Director, CDC, 1600 Clifton Road, NE., M/S/ D-24, Atlanta, Georgia 30333. Telephone 404/639-7060.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: September 28, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.